scispace - formally typeset
Journal ArticleDOI

Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+- induced dopaminergic neuronal cell death: Role of caspases, ROS, and JNK

Reads0
Chats0
TLDR
The possibility that MPTP and 6‐hydroxydopamine act on distinct cell death pathways in a murine dopaminergic neuronal cell line is examined, finding that cells treated with 6‐OHDA accompanied ultrastructural changes typical of apoptosis, whereas MPP+ treatment induced necrotic manifestations.
Abstract
In this study, we examined the possibility that MPTP and 6-hydroxydopamine (6-OHDA) act on distinct cell death pathways in a murine dopaminergic neuronal cell line, MN9D. First, we found that cells treated with 6-OHDA accompanied ultrastructural changes typical of apoptosis, whereas MPP+ treatment induced necrotic manifestations. Proteolytic cleavage of poly(ADP-ribose)polymerase by caspase was induced by 6-OHDA, whereas it remained uncleaved up to 32 h after MPP+ treatment and subsequently disappeared. Accordingly, 6-OHDA- but not MPP+-induced cell death was significantly attenuated in the presence of a broad-spectrum caspase inhibitor, N-benzyloxy-carbonyl-Val-Ala-Asp-fluomethylketone (Z-VAD-fmk). As measured by fluorometric probes, the level of reactive oxygen species (ROS) significantly increased after 6-OHDA treatment. In contrast, the level of dihydroethidium-sensitive ROS following MPP+ treatment remained unchanged while a slight increase in dichlorofluorescin-sentive ROS was temporarily observed. As demonstrated by immunoblot analysis, the level of superoxide dismutase was down-regulated following 6-OHDA treatment, whereas it remained unchanged after MPP+ treatment. Cotreatment of cells with antioxidants such as N-acetylcysteine or Mn(III)tetrakis(4-benzoic acid)porphyrin chloride (MnTBAP, cell-permeable superoxide dismutase mimetic) rescued 6-OHDA- but not MPP+-induced cell death, whereas inclusion of catalase or NG-nitro-l-arginine had no effect in both cases. In addition, 6-OHDA induced ROS-mediated c-Jun N-terminal kinase (JNK) activation that was attenuated in the presence of N-acetylcysteine or MnTBAP but not catalase or Z-VAD-fmk. In contrast, MPP+ has little effect on JNK activity, indicating that ROS and/or ROS-induced cell death signaling pathway seems to play an essential role in 6-OHDA–mediated apoptosis but not in MPP+-induced necrosis in a mesencephalon-derived, dopaminergic neuronal cell line. J. Neurosci. Res. 57:86–94, 1999. © 1999 Wiley-Liss, Inc.

read more

Citations
More filters
Journal ArticleDOI

Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease.

TL;DR: Recent data concerning the biochemical and molecular apoptotic mechanisms underlying the experimental models of PD are reported and correlates them to the phenomena occurring in human disease.
Journal ArticleDOI

Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century.

TL;DR: This review focuses in detail on the effectiveness of curcumin and its mechanism of actions in treating neurodegenerative diseases such as Alzheimer's and Parkinson’s diseases and brain malignancies.
Journal ArticleDOI

Involvement of protein kinase C activation and cell survival/ cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action.

TL;DR: The results suggest that the neuroprotective mechanism of EGCG against oxidative stress-induced cell death includes stimulation of PKC and modulation of cell survival/cell cycle genes.
Journal ArticleDOI

A Redox Modulatory Mn3O4 Nanozyme with Multi-Enzyme Activity Provides Efficient Cytoprotection to Human Cells in a Parkinson's Disease Model

TL;DR: The redox modulatory effect of Mn3 O4 plays a crucial role in protecting the cells from MPP+ induced cytotoxicity in a Parkinson disease (PD)-like cellular model, indicating that manganese-based nanomaterials having multi-enzyme activity can robustly rescue the Cells from oxidative damage and thereby possess therapeutic potential to prevent ROS-mediated neurological disorders.
Journal ArticleDOI

Parkinsonian Mimetics Induce Aspects of Unfolded Protein Response in Death of Dopaminergic Neurons

TL;DR: The involvement of UPR in these widely used neurotoxin models supports the role of ubiquitin-proteasome pathway dysfunction in PD.
References
More filters
Journal ArticleDOI

Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill

TL;DR: It was shown that phenol red does not interfere with the measurements and no washing steps are required since all ingredients can be added subsequently, and Serum proteins at concentrations up to 25% have no influence on the result.
Journal ArticleDOI

Aging, energy, and oxidative stress in neurodegenerative diseases.

TL;DR: Potential therapeutic approaches include glutamate release inhibitors, excitatory amino acid antagonists, strategies to improve mitochondrial function, free radical scavengers, and trophic factors, which appear promising in experimental studies and are now being applied to human studies.
Journal Article

Intracellular ATP levels determine cell death fate by apoptosis or necrosis

TL;DR: This study addressed the question of whether apoptosis depends on intracellular ATP levels, since longer incubation under ATP-depleting conditions results in necrotic cell death, and indicated that ATP levels are a determinant of manifestation of cell death.
Journal Article

Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease

TL;DR: Ulastructural examination revealed characteristics of apoptosis and autophagic degeneration in melanized neurons of the substantia nigra in PD patients, suggesting that even at the final stage of the disease, the dopaminergic neurons are undergoing active process of cell death.
Related Papers (5)